rs2303151

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000859.3(HMGCR):​c.2457+70C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0586 in 1,311,974 control chromosomes in the GnomAD database, including 2,744 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.056 ( 304 hom., cov: 32)
Exomes 𝑓: 0.059 ( 2440 hom. )

Consequence

HMGCR
NM_000859.3 intron

Scores

2

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: -0.673
Variant links:
Genes affected
HMGCR (HGNC:5006): (3-hydroxy-3-methylglutaryl-CoA reductase) HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
CERT1 (HGNC:2205): (ceramide transporter 1) This gene encodes a kinase that specifically phosphorylates the N-terminal region of the non-collagenous domain of the alpha 3 chain of type IV collagen, known as the Goodpasture antigen. Goodpasture disease is the result of an autoimmune response directed at this antigen. One isoform of this protein is also involved in ceramide intracellular transport. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HMGCRNM_000859.3 linkuse as main transcriptc.2457+70C>T intron_variant ENST00000287936.9 NP_000850.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HMGCRENST00000287936.9 linkuse as main transcriptc.2457+70C>T intron_variant 1 NM_000859.3 ENSP00000287936 P1P04035-1

Frequencies

GnomAD3 genomes
AF:
0.0557
AC:
8466
AN:
152124
Hom.:
303
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0339
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0754
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.183
Gnomad SAS
AF:
0.0317
Gnomad FIN
AF:
0.0852
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0544
Gnomad OTH
AF:
0.0550
GnomAD4 exome
AF:
0.0590
AC:
68431
AN:
1159732
Hom.:
2440
Cov.:
15
AF XY:
0.0574
AC XY:
33602
AN XY:
585080
show subpopulations
Gnomad4 AFR exome
AF:
0.0359
Gnomad4 AMR exome
AF:
0.0906
Gnomad4 ASJ exome
AF:
0.0188
Gnomad4 EAS exome
AF:
0.172
Gnomad4 SAS exome
AF:
0.0237
Gnomad4 FIN exome
AF:
0.0855
Gnomad4 NFE exome
AF:
0.0561
Gnomad4 OTH exome
AF:
0.0578
GnomAD4 genome
AF:
0.0557
AC:
8474
AN:
152242
Hom.:
304
Cov.:
32
AF XY:
0.0578
AC XY:
4306
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.0339
Gnomad4 AMR
AF:
0.0757
Gnomad4 ASJ
AF:
0.0167
Gnomad4 EAS
AF:
0.183
Gnomad4 SAS
AF:
0.0314
Gnomad4 FIN
AF:
0.0852
Gnomad4 NFE
AF:
0.0544
Gnomad4 OTH
AF:
0.0572
Alfa
AF:
0.0532
Hom.:
201
Bravo
AF:
0.0559
Asia WGS
AF:
0.114
AC:
395
AN:
3478

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Statins, attenuated cholesterol lowering by Other:1
drug response, no assertion criteria providedresearchDepartment of Cardiology, Chinese Academy of Medical Sciences, Fuwai HospitalNov 01, 2022- likely responsive

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.1
DANN
Benign
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2303151; hg19: chr5-74655451; API